Abstract Purpose: To investigate the toxicity of Labisia pumila standardized extract (LPE) and its liposomal extract (LLP
INTRODUCTION
Labisia pumila Blume, var. alata (Family: Myrsinaceae), known as Kacip Fatimah in Malaysia. Traditionally, L. pumila has been used due to its medicinal values in health products and female tonics. Furthermore, L. pumila is used in other ailments such as dysmenorrhoea, gonorrhoea, dysentery and flatulence [1] . Recent pharmacological studies have reported that L. pumila has phytoestrogenic, anti-agiogenesis, anticancer, antioxidant, antibacterial, antifungal, anti-aging and anti-inflammatoryactivities. The benefits of the traditional use of L. pumila have also been supported by identification and isolation of many active compounds including phenolics, flavonoids and resorcinol compounds [2] . Gallic acid (as one of the isolated compounds from this plant) possessed many pharmacological activities such as antioxidant, antiangiogenesis, antiobesity, and anticancer effects. Rutin is also reported for different pharmacological effects, for example hepatic protective, antidiabetic, antihypertensive, antiinflammatory, anticancer and antioxidant activities. Gallic acid and rutin both found in L. pumila extract [3] [4] [5] [6] [7] [8] . Sub-acute, teratogenic and reproductive toxicity studies of L. pumila water extract at (50, 1000 and 800 mg/kg), respectively without any side effects were reported [9] [10] [11] . The present study has been designed to perform the acute oral toxicity study at (2000 mg/kg) and repeated dose oral toxicity study of LPE and LLP at (250, 500 and 1000 mg/kg), respectively. Furthermore, the present study also describe authenticity of plant species, parts of plant, type of extract and method of extraction. So, this study was aimed to evaluate the acute and repeated dose oral toxicity studies on standardized L. pumila extract (LPE) and liposome of L. pumila (LLP).
EXPERIMENTAL

Chemical and reagents
Soybean lecithin was procured from Hong Aun kimia Sdn Bhd., Malaysia. Acetone, chloroform and ethanol were obtained from Quality Reagent Chemical Malaysia.
Preparation of LPE and LLP
The whole plant of L. pumila var. alata was extracted with ethanol (50%) using soxhlet apparatus. The crude extract was filtered, concentrated under reduced pressure using a rotary evaporator, and further dried in oven. The dried extract was then kept in the fridge at -20 o C prior to use. Liposome formulation of ethanol (50%) extract of L. pumila was prepared as described by [12] .
Acute oral toxicity study
Male and female Sprague Dawley rats at 8-10 weeks of age were used. The animals were acclimatized to laboratory conditions for a week prior to the experiment. The rats were housed with free access to feed (normal laboratory chow, Gold Coin) and tap water ad libitum. The rats were maintained at 28±2°C under a light/dark cycle of 12 h. All the procedures were done according to the OECD guidelines (2008) [13 and 15] and approved by the Animal Ethics Committee of Universiti Sains Malaysia (USM/Animal Ethics approval no. 2014/597).
LPE and LLP were administered orally (2000 mg/kg) in single doses to the rats (n=5). Another group of 5 rats without treatment was used as control group. The general behaviour of the rats were continuously monitored for 1 h after dosing, periodically during the first 24 h and daily thereafter for a total of 14 days. After 14 days of treatment, all animals were euthanized in CO 2 chamber, and selected vital organs were excised, weighed, and macroscopically examined [14] .
Repeated dose toxicity study
Animals (70 rats) were divided into 7 groups (5 rats/sex/group) and received the test materials orally. Group 1 served as control receiving vehicle only. Animals in group 2 to group 7 received 250, 500 and 1000 mg/kg of LPE or LLP, respectively. Animals were treated once daily consecutively for 28 days. The animals were observed daily for clinical signs and mortality. At the end of the experiment, animals were anaesthetized by sodium pentobarbitone and blood was collected by cardiac puncture from overnight fasted animals. Vital organs such as brain, heart, lungs, liver, spleen, kidneys, and testes/ovaries were removed and weighed. Haematological, biochemical and histological analysis were done [15] . Measurements were made by (Gribbles Lab., Penang, Malaysia).
Statistical analysis
Data are expressed as mean ± standard error of mean (SEM) and were analysed using Statistical Package for the Social Sciences (SPSS 20.0, IBM). The data were considered significant at p < 0.05.
RESULTS
Toxicity of LPE and LLP
For acute oral toxicity study, lethal effects were not observed after administration of LPE or LLP at dose (2000 mg/kg). No behavioural changes were observed during the observation period. There were no significant changes in the organto-body weight ratios (Table 1 ) of the treated rats compared to normal control group. Therefore, the LD 50 value for oral administration of LPE and LLP was greater than 2000 mg/kg.
In repeated dose oral toxicity study, there was no mortality of animals at any dose. Gross observations did not show any changes and all animals of both groups remain healthy. There were no abnormalities founded with respect to eye colour, touch response, salivation, grip strength and tail pinch. No locomotor dysfunction, convulsions or tremors were observed in all animals.
There were no significant differences observed for the weekly body weight and organ-to-body weight ratios of rats treated with LPE or LLP for 28 days ( Table 2 and Table 3 ) except for LLP 250 mg/kg, LPE 500 mg/kg, and LLP 500 mg/kg for female groups during 14 days as presented in Table 2 . The haematology results (Table 4) showed no statistically significant differences in the values for treated groups compared to normal control group except for haemoglobin (Hb), packed cell volume (PCV), mean cell volume (MCV), and neutrophiles in female groups only but still within the normal range as previously reported [16] . A biochemical examination results are summarized in Table 5 , the levels of biochemical parameters were not statistically significant compared to normal control groups except for urea and uric acid in female treated groups, and for total cholesterol (TC), triglycerides (TG), and high density lipoprotein (HDL) in female and male treated groups but remained within the normal range except for urea level in female treated groups (LPE 500 mg/kg and LLP at 250, 500, 1000 mg/kg). Among the indicators of liver function, alanine aminotransferase (ALT), Aspartate aminotransferase (AST) and alkaline phosphatase (ALP) were not affected by LPE or LLP in both male and female treated groups.
The histological examination of liver and kidney tissues of normal control group and treated groups did not show any pathological abnormalities. Both control and treated groups showed normal hepatic architecture. Mild periportal inflammation was seen in female and male normal control groups (only 1 out of 5 rats), female LPE 500 mg/kg group (only 1 out of 5 rats) and male LPE 250 and 1000 mg/kg groups (only 1 out of 5 rats), while it didn't show any periportal chronic inflammation in liver of LLP treated groups in both male and female rats. No ballooning degeneration, inflammation or other pathological abnormalities were observed in liver tissue samples of male and female rats (Plates 1 and 2). Kidney exhibited normal renal cortex containing normal glomeruli. Renal tubules were lined with typical cuboidal epithelium and had distinct lumen. Chronic pyelitis was observed in 1 female rat in normal control and LPE 1000 mg/kg groups (Plates 3 and 4). Thus these changes were not considered to be treatment related in this study, because these microscopic changes were observed in normal control group. 
DISCUSSION
Herbal medicines are gaining popularity in developing countries because of their less side effects. Such remedies are often believed to be harmless, since these treatments are "natural" and commonly used for self-medication without supervision. Although medicinal plants may cause several biological activities in humans, a little is known regarding the potential toxicity in many of these bioactive substances.
The results of acute toxicity study indicated that LPE and LLP didn't cause visible signs of toxicity or mortality. Generally, a reduction in body weight and internal organ weights is a simple and sensitive index of toxicity after exposure to potentially toxic substances [17] . In the present study, LPE and LLP (2000 mg/kg, per oral) did not significantly affect body or organ weight as compared to the normal control groups, which suggests that the extract did not disturb rat growth; this is with the agreement to the toxicity classification reported by (Loomis and Hayes 1996) [18] .
However a 28-days sub-chronic oral toxicity testing using repeated doses is widely considered satisfactory to assess any possible health hazard, and is important even for herbal supplements. The present results revealed that all parameters in term of organ-to-body weight ratios, haematological biochemical values were found normal between LPE and LLP treated groups compared to normal control group [16] . Histological examination of the vital organs including the liver and kidney from the treated and normal rats showed no apparent histological changes, chronic pyelitis (inflammation of renal pelvis and calyces), was only focally seen at pelvis of the kidney. It is often caused by ascending bacterial infection. The renal parenchyma was normal in this study. Overall the histological examination indicated evidence of safety at the tested doses when administered orally. The safety of treatment was also confirmed by the absence of behavioural changes and absence of difference in feed consumption between the treated and normal control groups. Hence, the results clearly showed that oral administration of LPE and LLP are safe at the evaluated doses (250, 500 and 1000 mg/Kg) in Sprague Dawley rats.
CONCLUSION
The acute and repeated dose oral toxicity assay of LPE and LLP could be very useful in its future clinical studies. LPE and LLP seemed to be nontoxic as was seen after its acute and repeated dose oral administrations. The oral lethal dose is in excess of 1000 mg/kg. The no-adverse-effectlevel from the present study was determined to be 1000 mg/kg per day for rats under the condition tested. 
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